This process facilitates the release of cellular contents and pro-inflammatory cytokines such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), thereby amplifying inflammatory responses and accelerating CKD progression [45,46]. Here, IL18 is linked to chronic kidney disease.